Risk factors and clinical analysis of candidemia in very-low-birth-weight neonates

American Journal of Infection Control

Volumn 44, Issue 11, 2016, Pages 1321-1325

  Fu, Jinjian ^a   Wang, Xingmin ^a   Wei, Ba ^a   Jiang, Yongjiang ^a   Chen, Jichang ^a  

^a Liuzhou Maternity and Child Health Care Hospital   (China)

Author keywords

Case control study; Risk factors

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; LUNG SURFACTANT; PIPERACILLIN PLUS TAZOBACTAM; STEROID; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTIFUNGAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDEMIA; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CHRONOPHARMACOLOGY; CLINICAL ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; EXTREMELY LOW BIRTH WEIGHT; FEMALE; FUNGUS ISOLATION; GENDER; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; INFECTION RISK; LENGTH OF STAY; MALE; MATERNAL DISEASE; MENTAL DISEASE; MORTALITY RATE; NEWBORN; NEWBORN INFECTION; NEWBORN MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; VERY LOW BIRTH WEIGHT; CANDIDA; CHINA; CLASSIFICATION; CROSS INFECTION; HOSPITAL; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES;

CANDIDA; CANDIDEMIA; CASE-CONTROL STUDIES; CHINA; CROSS INFECTION; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INFECTION CONTROL; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84994071228     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.03.026     Document Type: Article

References (31)

1. 1 Makhoul, I.R., Sujov, P., Smolkin, T., Lusky, A., Reichman, B., Epidemiological, clinical and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 109 (2002), 34–39.
2. 2 Stoll, B.J., Hansen, N., Fanaroff, A.A., Wright, L.L., Carlo, W.A., Ehrenkranz, R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 110 (2002), 285–291.
3. 3 Pfaller, M.A., Moet, G.J., Messer, S.A., Jones, R.N., Castanheira, M., Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial surveillance program, 2008-2009. Antimicrob Agents Chemother 55 (2011), 561–566.
4. 4 Benjamin, D.K. Jr, Stool, B.J., Gantz, M.G., Walsh, M.C., Sánchez, P.J., Das, A., et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126 (2010), 865–873.
5. 5 Ben Abdeljelil, J., Saghrouni, F., Nouri, S., Geith, S., Khammari, I., Fathallah, A., et al. Neonatal invasive candidiasis in Tunisian hospital: incidence, risk factors, distribution of species and antifungal susceptibility. Mycoses 55 (2012), 493–500.
6. 6 Mahieu, L.M., De Muynck, A.O., De Dooy, J.J., Laroche, S.M., Van Acker, K.J., Prediction of nosocomial sepsis in neonates by means of a computer-weighted bedside scoring system (NOSEP Score). Crit Care Med 28 (2000), 2026–2033.
7. 7 Yu, Y.F., Du, L.Z., Yuan, T.M., Zheng, J.Y., Chen, A., Chen, L.H., et al. Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients. Am J Perinatol 30 (2013), 589–594.
8. 8 Zaoutis, T.E., Greves, H.M., Lautenbach, E., Bilker, W.B., Coffin, S.E., Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 23 (2004), 635–641.
9. 9 Bayley, N., Bayley Scales of Infant Development II. San Antonio, Tex: Psychological Corp, 1993.
10. 10 Stoll, B.J., Hansen, N.I., Adams-Champman, I., Fanaroff, A.A., Hintz, S.R., Vohr, B., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292 (2004), 2357–2365.
11. 11 Karadag-Oncel, E., Kara, A., Ozsurekci, Y., Arikan-Akdagli, S., Cengiz, A.B., Ceyhan, M., et al. Candidaemia in a paediatric centre and importance of central venous catheter removal. Mycoses 58 (2015), 140–148.
12. 12 Saiman, L., Ludington, E., Pfaller, M., Rangel-Frausto, S., Wiblin, R.T., Dawson, J., et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The national epidemiology of mycosis survey study group. Pediatr Infect Dis J 19 (2000), 319–324.
13. 13 Manzoni, P., Jacqz-Aigrain, E., Rizzollo, S., Franco, C., Stronati, M., Mostert, M., et al. Antifungal prophylaxis in neonates. Early Hum Dev 87 (2011), S59–60.
14. 14 Arendrup, M.C., Epidemiology of invasive candidiasis. Curr Opin Crit Care 16 (2010), 445–452.
15. 15 Oeser, C., Vergnano, S., Naidoo, R., Anthony, M., Chang, J., Chow, P., et al. Neonatal invasive fungal infection in England 2004-2010. Clin Microbiol Infect 20 (2014), 936–941.
16. 16 Ding, X., Yan, D., Sun, W., Zeng, Z., Su, R., Su, J., Epidemiology and risk factors for nosocomial Non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med Mycol 53 (2015), 684–690.
17. 17 Pfaller, M.A., Diekema, D.J., Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 (2007), 133–163.
18. 18 Wu, Z., Liu, Y., Feng, X., Liu, Y., Wang, S., Zhu, X., et al. Candidemia: incidence rates, types of species, and risk factors at a tertiary care academic hospital in China. Int J Infect Dis 22 (2014), 4–8.
19. 19 Zhang, X.B., Yu, S.J., Yu, J.X., Gong, Y.L., Feng, W., Sun, F.J., Retrospective analysis of epidemiology and prognostic factors for candidemia at a hospital in China, 2000-2009. Jpn J Infect Dis 65 (2012), 510–515.
20. 20 Xia, H., Wu, H., Xia, S., Zhu, X., Chen, C., Qu, G., et al. Invasive candidiasis in preterm neonates in China: a retrospective study from 11 NICUS during 2009-2011. Pediatr Infect Dis J 33 (2014), 106–109.
21. 21 Zaoutis, T.E., Argon, J., Chu, J., Berlin, J.A., Walsh, T.J., Feudtner, C., The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41 (2005), 1232–1239.
22. 22 Pappas, P.G., Rex, J.H., Lee, J., Hamill, R.J., Larsen, R.A., Powderly, W., et al. NIAID Mycoese Study Group. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37 (2003), 634–643.
23. 23 Filioti, J., Spiroglou, K., Panteliadis, C.P., Roilides, E., Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med 33 (2007), 1272–1283.
24. 24 Sendid, B., Cotteau, A., Francois, N., D'Haveloose, A., Standaert, A., Camus, D., et al. Candidaemia and antifungal therapy in a French university hospital: rough trends over a decade and possible links. BMC Infect Dis 6 (2006), 80–88.
25. 25 Clerihew, L., Lamagni, T.L., Brocklehurst, P., McGuire, W., Invasive fungal infection in very low birth weight infants: national prospective surveillance study. Arch Dis Child Fetal Neonatal Ed 91 (2006), F188–92.
26. 26 Benjamin, D.K. Jr, Delong, E.R., Steinbach, W.J., Cotton, C.M., Walsh, T.J., Clark, R.H., Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 112 (2003), 543–547.
27. 27 Horn, D.L., Neofytos, D., Anaissie, E.J., Fishman, J.A., Steinbach, W.J., Olyaei, A.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48 (2009), 1695–1703.
28. 28 Rolides, E., Invasive candidiasis in neonates and children. Early Hum Dev 87:Suppl 1 (2011), S75–6.
29. 29 Benjamin, D.K. Jr, Stoll, B.J., Fanaroff, A.A., McDonald, S.A., Oh, W., Higgins, R.D., et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117 (2006), 84–92.
30. 30 Oeser, C., Lamagni, T., Heath, P.T., Sharland, M., Ladhani, S., The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. Pediatr Infect Dis J 32 (2013), 23–26.
31. 31 Cisterna, R., Ezpeleta, G., Telleria, O., Spanish Candidemia Surveillance Group. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol 48 (2010), 4200–4206.